Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market

February 21, 2011 By Bio-Medicine.Org

BELOIT, Wis., Feb. 21, 2011 /PRNewswire/ — Sheffield
Bio-Science, a Kerry Group Business, has formed a strategic global
sales, marketing and development alliance with Wockhardt Ltd. Under
this partnership, Sheffield Bio-Science will be the Exclusive
Global Sales and Distribution Partner for recombinant insulin
manufactured by global Indian biotech Wockhardt. According to
estimates, the potential in cell culture markets is around US$ 50
million.

Speaking on this landmark alliance, Dr. Habil Khorakiwala,
Chairman, Wockhardt Group stated, “This partnership is a
reaffirmation of Wockhardt’s biotechnology research prowess and a
confluence of innovative novel technology now being offered to
global cell culture markets.”

Sheffield’s Director of Global Business Development, Hans
Huttinga, stated, “We are looking forward to developing a strong
and lasting partnership between our organizations.”

Wockhardt was the first in Asia and only the fourth company in
the world to have developed, manufactured and marketed Wosulin
– recombinant insulin injectables. Wockhardt’s
state-of-the-art Biotech Park in Aurangabad has six dedicated
manufacturing facilities and was inaugurated by the then President
of India, His Excellency, Dr. APJ Abdul Kalam.

“This strategic alliance marks another step in our continued
investment to strengthen our cell culture media supplement
portfolio,” said Edmond Scanlon, President of Sheffield
Bio-Science.

Sheffield Bio-Science continues its evolution to deliver a
complete novel technology platform to the global cell culture
market. Customers will now have greater access to the industry’s
most innovative and extensive cell culture media
ingredient-technologies, including recombinant proteins, chemically
defined metabolic enhancers, hydrolyzed proteins, and yeast
extracts. Such high quality solutions make it easier for
biopharmaceutical manufacturers to delay apoptosis and maximize
product yields.

About Sh

‘/>”/>

SOURCE

Related Articles Read More >

CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech